Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-21

Clinical Trial Update: This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing a single combination pill of empagliflozin, linagliptin, and metformin versus separate pills in healthy participants has completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)
  • Empagliflozin/linagliptin/metformin combination pill
  • Linagliptin (linagliptin)
  • metformin (metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2020-02-21